Encinitas, CA, United States of America

John E Stuelpnagel

This inventor holds 1 USPTO granted patent. Top assignee: Illumina Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John E Stuelpnagel. Retrieved from https://idiyas.com/inventor/john-e-stuelpnagel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 215(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John E. Stuelpnagel

Introduction

John E. Stuelpnagel is a prominent inventor based in Encinitas, California. He is known for his significant contributions to the field of biotechnology, particularly in the area of nucleic acid amplification and genotyping. His work has paved the way for advancements in genetic research and diagnostics.

Latest Patents

Stuelpnagel holds a patent for "Multiplex nucleic acid reactions." This invention is directed to a variety of multiplexing methods used to amplify and/or genotype a variety of samples simultaneously. His innovative approach has enhanced the efficiency and accuracy of genetic testing.

Career Highlights

Stuelpnagel is associated with Illumina Corporation, a leading company in the field of genomics. His role at Illumina has allowed him to work on cutting-edge technologies that are transforming the landscape of genetic research and personalized medicine.

Collaborations

Throughout his career, Stuelpnagel has collaborated with notable colleagues, including Mun-Jui Richard Shen and Arnold Oliphant. These partnerships have contributed to the development of innovative solutions in the biotechnology sector.

Conclusion

John E. Stuelpnagel's contributions to the field of biotechnology through his patent and work at Illumina Corporation highlight his role as a key innovator in genetic research. His advancements continue to influence the future of genetic testing and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…